Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

Dry Eye Syndrome Treatment Market to be worth US$

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
(Total Views: 57)
Posted On: 12/13/2017 5:00:27 AM
Avatar
Posted By: News Desk 2018
Dry Eye Syndrome Treatment Market to be worth US$ 6,610 Mn by 2027; Launch of Innovative Products to Drive Growth of Market, Notes FMI

Valley Cottage, New York, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Some of the key players in the global market for dry eye syndrome treatment include names such as Nicox, Candorvision, Novartis, Allergan Inc., Santen Pharmaceutical Co. Ltd., and Bridge Pharma Inc. among others. Among these companies, Santen, Novartis, and Allergen have made a dominant progress in the global market for dry eye syndrome treatment and are projected to continue their dominance over the course of the given forecast period of 2017 to 2027. In addition to this, the companies in the market are constantly striving to gain an upper hand over their rivals. As a result, they are engaging into strategic business activities such as partnerships, takeovers, and mergers to enhance their overall market presence.

According to the latest report by Future Market Insights, the  global market for dry eye syndrome treatment is projected to be valued around US$3.56 Bn by the end of 2017. Furthermore, the market is projected to growth and is estimated to be valued at about US$6.61 Bn by the end of the given forecast period in 2027. The overall growth of the global dry eye syndrome treatment market is expected to be achieved with the help of a strong CAGR 6.4% over the course of the aforementioned forecast period of 2017 to 2027.

Get Research Report Sample:   https://www.futuremarketinsights.com/reports/...ep-gb-1215

From a geographical standpoint, the global market for dry eye syndrome treatment can be segmented into key regions such as North America, Latin America, Europe, Middle East and Africa, and Asia Pacific except Japan. Of these, the global market is expected to be dominated by North America. The overall valuation of the North America market for dry eye syndrome treatment is expected to reach more than US$2.5 Bn. This growth of the market is expected to be achieved with the help of an impressive CAGR of 6.7% during the given forecast period. The North America market is expected to offer a lucrative business opportunity of US$88.6 Mn in year 2018. Moreover, the market is estimated to create growing opportunities worth US$1.207 Bn from 2017 to 2027.

By the fall of 2027, the APEJ market for dry eye syndrome treatment is expected to reach a figure worth US$878.7 Mn. This growth of the APEJ market is expected to be achieved with the help of an impressive CAGR of 7.4% during the given forecast period. The APEJ market for dry eye syndrome treatment is projected to present an absolute business opportunity of around US$29.7 Mn in 2018 over 2017. The market is also expected to create an incremental business opportunities worth US$446.4 Mn during the period of 2017 to 2027.

Browse Report ToC:   https://www.futuremarketinsights.com/reports/...market/toc

Product Innovations to Drive Growth of Market

More and more supplements producers are developing products specifically targeting at dry eye. One of the major reason for this is LASIK is becoming highly mainstream, and almost everyone who undergoes LASIK surgery will suffer from the dry eye syndrome within the first six months of their treatment. It is one of the chief driving factors for the growth of the global dry eye syndrome treatment market. Another important factor responsible for the growth of the global market is the launch of new product in the market. Recently, Candorvision introduced the CALMO eye spray which is the first eye spray free of preservatives in Canada. The leading players in the market are trying to create products that will take care of dry eye in different delivery channels so as to make sure better compliance of patients and utilization along with ample revenue generations.

No Price Regulations to Impede Market Growth

However, there are some factors that may impede the overall growth of the market in the coming years. One of the chief restraining factor for the growth of the global market is expected to be no control on the prices of the products. Without proper regulations on the prices, it might be difficult for the dry eye care products to reach masses.

Get Full Research Report:   https://www.futuremarketinsights.com/checkout/1215

About Us  

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us

Future Market Insights 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F : +1-845-579-5705 T (UK): +44(0)20-7692-8790 Sales: sales@futuremarketinsights.com Website :  http://www.futuremarketinsights.com



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us